New carbapenemase inhibitors: clearing the way for the β-lactams
JC Vázquez-Ucha, J Arca-Suárez, G Bou… - International journal of …, 2020 - mdpi.com
Carbapenem resistance is a major global health problem that seriously compromises the
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …
Beta-lactamase inhibitors: agents to overcome bacterial resistance.
SN Maiti, OA Phillips, RG Micetich… - Current medicinal …, 1998 - europepmc.org
The extensive use of beta-lactam antibiotics in hospitals and community has created major
resistance problems leading to increased morbidity, mortality and health-care costs …
resistance problems leading to increased morbidity, mortality and health-care costs …
Carbapenemases: molecular diversity and clinical consequences
L Poirel, JD Pitout, P Nordmann - Future microbiology, 2007 - Taylor & Francis
Carbapenemases are β-lactamases that hydrolyze most β-lactams including carbapenems.
Carbapenemases are classified in four molecular classes; those belonging to class A are …
Carbapenemases are classified in four molecular classes; those belonging to class A are …
Carbapenemases: the versatile β-lactamases
AM Queenan, K Bush - Clinical microbiology reviews, 2007 - Am Soc Microbiol
Carbapenemases are β-lactamases with versatile hydrolytic capacities. They have the ability
to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems. Bacteria …
to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems. Bacteria …
Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement?
JR Edwards, MJ Betts - Journal of Antimicrobial Chemotherapy, 2000 - academic.oup.com
This article provides a perspective on carbapenems, two examples of which,
imipenem/cilastatin and meropenem, are currently available for clinical use. Another …
imipenem/cilastatin and meropenem, are currently available for clinical use. Another …
The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria
D Hammoudi Halat, C Ayoub Moubareck - Antibiotics, 2020 - mdpi.com
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
The impact of carbapenemases on antimicrobial development and therapy.
DM Livermore - Current opinion in investigational drugs (London …, 2002 - europepmc.org
Carbapenems have been the most successful beta-lactam antibiotics in evading bacterial
resistance. Nevertheless, acquired carbapenemases are increasingly reported, mostly in …
resistance. Nevertheless, acquired carbapenemases are increasingly reported, mostly in …
β-Lactamase inhibitors: the story so far
FJ Perez-Llarena, G Bou - Current medicinal chemistry, 2009 - ingentaconnect.com
Antimicrobial resistance constitutes one of the major threats regarding pathogenic
microorganisms. Gramnegative pathogens, such as Enterobacteriaceae (specially those …
microorganisms. Gramnegative pathogens, such as Enterobacteriaceae (specially those …
The battle is on: new beta-lactams for the treatment of multidrug-resistant Gram-negative organisms
Abstract Purpose of Review Resistant gram-negative infections are becoming increasingly
difficult to treat, prompting increased focus on drug development. This review will focus …
difficult to treat, prompting increased focus on drug development. This review will focus …
Structural and functional aspects of class A carbapenemases
The fight against infectious diseases is probably one of the greatest public health challenges
faced by our society, especially with the emergence of carbapenem-resistant gram …
faced by our society, especially with the emergence of carbapenem-resistant gram …